Formulation and In Vitro Release Studies of Emulgels Containing Shea Butter and Diclofenac Diethylamine
Abstract
Shea butter is a raw material widely used in cosmetology. Its use in the pharmaceutical sector is becoming increasingly popular. As it’s commonly produced in Burkina Faso, it can help reduce medicine costs. Several dermatological formulations (creams, body milks, ointments) have been developed in our laboratories in Burkina Faso. However, some active ingredients are not compatible with those bases due to their hydrophilic-lipophilic balance. The emulgel form can thus be a solution. Moreover, this type of dermatological base has not yet been reported in the literature on shea butter. The main objective of our study was to develop an emulgel based on shea butter, and diclofenac diethylamine was chosen as the active ingredient. Emulgel formulations were prepared with shea butter, carbomer 980, or arabic gum and diclofenac diethylamine. Physical quality control was performed against the Diclofenac Reference emulgel. The better emulgel formulations were tested for in vitro release of diclofenac diethylamine, compared with the Diclofenac Reference emulgel. The formulated emulgel was homogeneous, whitish in colour. The pH ranged from 6.53 to 6.71. The emulgel made with 0.5% carbomer 980 had a viscosity close to that of the Diclofenac Reference emulgel. Their diclofenac diethylamine content conformed to standards (99.47% and 100.55%). The release rate of these formulations after 6 hours ranged from 58.66% to 66.26%. The diclofenac reference emulgel had a lower rate of 44.02%. Locally produced shea butter can thus be used to formulate an emulgel incorporating diclofenac diethylamine as the active ingredient.
Keywords: Diclofenac diethylamine, emulgel, shea butter, carbomer, arabic gum.
Keywords:
Diclofenac diethylamine, emulgel, shea butter, carbomer, arabic gumDOI
https://doi.org/10.22270/jddt.v16i1.7527References
(1) Baibhav, J.; Gurpreet, S.; Rana, A. C.; Seema, S. Development and Characterization of Clarithromycin Emulgel for Topical Delivery. Int J Drug Dev Res 2012;4(3):310-323.
(2) Fontenau, J.; Klusiewiez, P. Travaux Pratiques et de Conditionnement Des Médicaments; Recueil-Malmaison : Prophyre, 2008.
(3) Lebert O. Le Karité et Le Henné ; Deux Matières Premières Africaines à Fort Pouvoir Culturel Local Utilisées Dans Les Cosmétiques., Université de Nante, France, 2005.
(4) Van der Vossen HAM; Mkamilo GS. Ressources Végétales de l'Afrique Tropicale 14. Oléagineux., PROTA Wagenigen.; Pays Bas, 2007.
(5) Institut Bioforce Développement. La Professionnalisation de La Chaîne d'approvisionnement Des Produits de Santé En Afrique de l'ouest. Enquête Régionale Afrique de l'Ouest.; 2012.
(6) Toe NLS; Semde R; Barro-Traoré F; Traoré A; Guissou IP. Formulation de Crèmes et Laits Cosmétiques à Base Du Beurre de Karité Du Burkina Faso. Ann. Dermatol. Vénéréologie 2007;134((SUP1)):54-62. https://doi.org/10.1016/S0151-9638(07)89082-X
(7) Bagaya M. Essais de Formulation Des Crèmes et Laits Dermatologiques à Base de Beurre de Karité Raffine et d'acide Salicylique. Thèse de doctorat en Pharmacie N°234, Université de Ouagadougou, 2014.
(8) Zime-Diawara, H.; Sombie, C.; Ouedraogo, S.; Ouedraogo, M.; Dori, D.; Yameogo, J.; Semde, R. Essais de Formulation de Crèmes et de Pommades Dermatologiques à base de Beurre de Karité Raffiné et de Dipropionate de Bétamethasone. J. Afr. Technol. Pharm. Biopharmacie JATPB, 2025;4(2):54-66. https://doi.org/10.57220/jatpb.v4i2.225
(9) Wolfe, M. M.; Lichtenstein, D. R.; Singh, G. Gastrointestinal Toxicity of Nonsteroidal Antiinflammatory Drugs. N. Engl. J. Med. 1999;340(24):1888-1899. PMid:10369853 https://doi.org/10.1056/NEJM199906173402407
(10) British Pharmacopoeia; Vol. Vol III. 2021.
(11) FDA 1997, . Guidance for Industry : Nonsterile Semisolid Dosage Form ScaleUp and Postapproval Changes : Chemistry, Manufacturing, and Controls ; In Vitro Release Testing and In Vivo Bioequivalence Documentation. SUPACSS.Guidance. Rockville, MD, USA, U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER).
(12) Liebenberg, W.; Engelbrecht, E.; Wessels, A.; Devarakonda, B.; Yang, W.; De, V. M. A Comparative Study of the Release of Active Ingredients from Semisolid Cosmeceuticals Measured with Franz, Enhancer or Flow-through Cell Diffusion Apparatus. J. Food Drug Anal. 2004;12(1):10. https://doi.org/10.38212/2224-6614.2669
(13) Klein, S. Influence of Different Test Parameters on in Vitro Drug Release from Topical Diclofenac Formulations in a Vertical Diffusion Cell Setup. Pharm.- Int. J. Pharm. Sci. 2013;68(7):565-571.
(14) Martini MC. Introduction à La Dermopharmacie et à La Cosmétologie, 1ère édition.; Lavoisier: France, 2003.
(15) Jain, A.; Deveda, P.; Vyas, N.; Chauhan, J.; Khambete, H.; Jain, S. Development of Antifungal Emulsion Based Gel for Topical Fungal Infection (s). IJPRD 2011;2(12):18-22.
(16) Sah, S. K.; Badola, A.; Mukhopadhyay, S. Development and Evaluation of Tioconazole Loaded Emulgel. Int J Appl Pharm 2017;9(5):83-90. https://doi.org/10.22159/ijap.2017v9i5.20046
(17) Tanaji, D. N. Emulgel: A Comprehensive Review for Topical Delivery of Hydrophobic Drugs. Asian J. Pharm. AJP 2018;12(02).
(18) Haneefa, K. M.; Easo, S.; Hafsa, P. V.; Mohanta, G. P.; Nayar, C. Emulgel: An Advanced Review. J. Pharm. Sci. Res. 2013;5(12):254.
(19) Goebel, K.; Sato, M. E. O.; Souza, D. F. de; Murakami, F. S.; Andreazza, I. F. In Vitro Release of Diclofenac Diethylamine from Gels: Evaluation of Generic Semisolid Drug Products in Brazil. Braz. J. Pharm. Sci. 2013;49:211-219. https://doi.org/10.1590/S1984-82502013000200003
(20) Silva, J. A. da; Santana, D. P. de; Bedor, D. G. C.; Borba, V. F. da C.; Lira, A. A. M.; Egito, E. S. T. do. In Vitro Release and Permeation of a Diclofenac Diethylamine from Microemulsion Gel-Like. Quím. Nova 2009;32:1389-1393. https://doi.org/10.1590/S0100-40422009000600005
Published
Abstract Display: 25 
PDF Downloads: 13 PDF Downloads: 1 How to Cite
Issue
Section
Copyright (c) 2026 Hermine ZIME DIAWARA, Hyacinthe W. BONKOUGOU, Charles B. SOMBIE , Salfo OUEDRAOGO , Luc ZONGO , Josias B. G. YAMEOGO , Rasmané SEMDE
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.